Closed
1 CPD Points
Statin (3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor)-based therapy for hepatitis C virus (HCV) infection-related diseases in the era of direct-acting antiviral agents
Start date
(not set)
End date
(not set)
Time
10:30 AM
Location
World Continuing Education Alliance eLearning System
Cost
CPD points
1
About this activity
Statin (3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor)-based therapy for hepatitis C virus (HCV) infection-related diseases in the era of direct-acting antiviral agents